CMS warns of Medicare Rx fraud

2 July 2006

The Centers for Medicare and Medicaid Services (CMS) has issued an alert to potential US Medicare Part D prescription drug beneficiaries about attempted frauds carried out by telephone canvassers (Marketletter June 26).

The scams, known as "$299 Ring" schemes, offer low-cost Medicare coverage to senior citizens and the disabled. Four bogus operators were named: Pharma Corp, National Medical Office, Medicare National Office and National Medicare. Prices offered range from $350-$379. The CMS is aware of at least 250 cases of the attempted fraud.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight